Cholesterol-lowering agents as treatment for psychological and cognitive disorders

摘要

Provided are methods for treating a membrane fluidity-related cognitive or psychological disorder in a human patient. The methods include the steps of: (a) performing a diagnostic test on the patient to determine that the patient has a cognitive or psychological disorder, and (b) administering to the patient a cholesterol-lowering agent in an amount sufficient to lower the serum cholesterol of the patient enough to increase brain membrane fluidity adequately to treat the cognitive or psychological disorder.